What our CEOs Say - Maggie Smallwood, BioVale

Maggie took a degree in Biochemistry and Microbiology as a mature student at the University of Leeds in the UK, followed by a PhD in Plant Science. She worked as Research Manager at a spin-out company in the early nineties and then joined the University of York to develop and manage large strategic research collaborations with industry focused on high-value compounds from plants. She helped conceive and manage a project funded by the Bill and Melinda Gates that was successful in developing a variety of the medicinal plant, Artemisia annua that is now used in production of artemisinin for treating malaria in the developing world.

Maggie Smallwood, CEO BioVale